Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1955 2
1956 1
1958 2
1959 7
1960 5
1961 5
1962 1
1963 11
1964 7
1965 7
1966 2
1967 8
1968 4
1969 4
1970 4
1971 6
1972 7
1973 13
1974 5
1975 5
1976 8
1977 5
1978 8
1979 8
1980 10
1981 8
1982 10
1983 12
1984 8
1985 13
1986 13
1987 9
1988 11
1989 8
1990 7
1991 12
1992 8
1993 8
1994 9
1995 7
1996 12
1997 5
1998 11
1999 5
2000 5
2001 9
2003 2
2004 7
2005 6
2006 4
2007 5
2008 6
2009 10
2010 6
2011 5
2012 3
2013 5
2014 7
2015 6
2016 5
2017 9
2018 5
2019 2
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

427 results
Results by year
Filters applied: . Clear all
Page 1
[O.E. Iversen replies].
Iversen OE. Iversen OE. Tidsskr Nor Laegeforen. 2013 Oct 1;133(18):1909. doi: 10.4045/tidsskr.13.1192. Tidsskr Nor Laegeforen. 2013. PMID: 24084953 Free article. Norwegian. No abstract available.
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.
Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, Pitisuttithum P, Restrepo JA, Stuart G, Woelber L, Yang YC, Cuzick J, Garland SM, Huh W, Kjaer SK, Bautista OM, Chan IS, Chen J, Gesser R, Moeller E, Ritter M, Vuocolo S, Luxembourg A; Broad Spectrum HPV Vaccine Study. Joura EA, et al. Among authors: iversen oe. N Engl J Med. 2015 Feb 19;372(8):711-23. doi: 10.1056/NEJMoa1405044. N Engl J Med. 2015. PMID: 25693011 Free article. Clinical Trial.
Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population.
Giuliano AR, Joura EA, Garland SM, Huh WK, Iversen OE, Kjaer SK, Ferenczy A, Kurman RJ, Ronnett BM, Stoler MH, Bautista OM, Moeller E, Ritter M, Shields C, Luxembourg A. Giuliano AR, et al. Among authors: iversen oe. Gynecol Oncol. 2019 Jul;154(1):110-117. doi: 10.1016/j.ygyno.2019.03.253. Epub 2019 Apr 11. Gynecol Oncol. 2019. PMID: 30982556 Free article. Clinical Trial.
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, Mayrand MH, Ruiz-Sternberg AM, Stapleton JT, Wiley DJ, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Cuzick J, Garland SM, Kjaer SK, Bautista OM, Haupt R, Moeller E, Ritter M, Roberts CC, Shields C, Luxembourg A. Huh WK, et al. Among authors: iversen oe. Lancet. 2017 Nov 11;390(10108):2143-2159. doi: 10.1016/S0140-6736(17)31821-4. Epub 2017 Sep 5. Lancet. 2017. PMID: 28886907 Clinical Trial.
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials.
Moreira ED Jr, Block SL, Ferris D, Giuliano AR, Iversen OE, Joura EA, Kosalaraksa P, Schilling A, Van Damme P, Bornstein J, Bosch FX, Pils S, Cuzick J, Garland SM, Huh W, Kjaer SK, Qi H, Hyatt D, Martin J, Moeller E, Ritter M, Baudin M, Luxembourg A. Moreira ED Jr, et al. Among authors: iversen oe. Pediatrics. 2016 Aug;138(2):e20154387. doi: 10.1542/peds.2015-4387. Epub 2016 Jul 15. Pediatrics. 2016. PMID: 27422279 Free article.
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.
Iversen OE, Miranda MJ, Ulied A, Soerdal T, Lazarus E, Chokephaibulkit K, Block SL, Skrivanek A, Nur Azurah AG, Fong SM, Dvorak V, Kim KH, Cestero RM, Berkovitch M, Ceyhan M, Ellison MC, Ritter MA, Yuan SS, DiNubile MJ, Saah AJ, Luxembourg A. Iversen OE, et al. JAMA. 2016 Dec 13;316(22):2411-2421. doi: 10.1001/jama.2016.17615. JAMA. 2016. PMID: 27893068 Clinical Trial.
Pathology.
Iversen OH, De Vries MJ, Olsen A. Iversen OH, et al. Med Teach. 1979;1(6):281-8. doi: 10.3109/01421597909014337. Med Teach. 1979. PMID: 24483301
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM. Muñoz N, et al. Among authors: iversen oe. J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5. J Natl Cancer Inst. 2010. PMID: 20139221 Clinical Trial.
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
FUTURE I/II Study Group, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Maansson R, Lu S, Vuocolo S, Hesley TM, Barr E, Haupt R. FUTURE I/II Study Group, et al. Among authors: iversen oe. BMJ. 2010 Jul 20;341:c3493. doi: 10.1136/bmj.c3493. BMJ. 2010. PMID: 20647284 Free PMC article. Clinical Trial.
[Pregnancy must be excluded before initiation of birth control].
Iversen OE, Hagerup-Jenssen T, Grammeltvedt G. Iversen OE, et al. Tidsskr Nor Laegeforen. 2019 Mar 19;139(6). doi: 10.4045/tidsskr.19.0137. Print 2019 Mar 26. Tidsskr Nor Laegeforen. 2019. PMID: 30917636 Free article. Norwegian. No abstract available.
427 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page